Divestiture • Life Science

Charles River Laboratories International Acquires Galapagos NV - CRO Services Division

On March 13, 2014, Charles River Laboratories International acquired life science company Galapagos NV - CRO Services Division from Galapagos for 129M EUR

Acquisition Context
  • This is Charles River Laboratories International’s 8th transaction in the Life Science sector.
  • This is Charles River Laboratories International’s 9th largest (disclosed) transaction.
  • This is Charles River Laboratories International’s 1st transaction in Belgium.

Explore All 789 Divestiture Life Science Deals - Search the Database Free


M&A Deal Summary

Date March 13, 2014
Target Galapagos NV - CRO Services Division
Sector Life Science
Buyer(s) Charles River Laboratories International
Sellers(s) Galapagos
Deal Type Divestiture
Deal Value 129M EUR

Target Company

Galapagos NV - CRO Services Division

Mechelen, Belgium
The CRO services division of Galapagos NV, which includes both Argenta and BioFocus are global leaders in integrated drug discovery services, with a predominant focus on in vitro capabilities.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Charles River Laboratories International

Wilmington, Massachusetts, United States

Category Company
Founded 1947
Sector Life Science
Employees18,700
Revenue 4.1B USD (2024)
DESCRIPTION

Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.


Deal Context for Buyer #
Overall 9 of 31
Sector: Life Science 8 of 28
Type: Divestiture 2 of 4
Country: Belgium 1 of 1
Year: 2014 1 of 5
Size (of disclosed) 9 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-07 Vital River Laboratories Co.

Beijing, China

Vital River Laboratories Co. Ltd. is a provider of research models and related services in China.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-03-31 Argenta Discovery 2009

Harlow, United Kingdom

Argenta Discovery 2009 Ltd. is a drug discovery company.

Buy -

Seller Profile 1

SELLER

Galapagos

Mechelen, Belgium

Category Company
Founded 1999
Sector Life Science
Employees683
Revenue 276M EUR (2024)
DESCRIPTION

Galapagos is a clinical stage biotech company focused on developing novel mode of action medicines. Galapagos was incorporated in 1999 and is based in Mechelen, Belgium.


Deal Context for Seller #
Overall 1 of 4
Sector: Life Science 1 of 4
Type: Divestiture 1 of 4
Country: Belgium 1 of 1
Year: 2014 1 of 3
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-06-01 Compound Focus

385 Oyster Point Boulevard Suite 1, California, United States

Compound Focus, Inc. is a small molecule compound management services.

Buy €13M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-03-31 Argenta Discovery 2009

Harlow, United Kingdom

Argenta Discovery 2009 Ltd. is a drug discovery company.

Sell -

Explore Related M&A Activity